# RYZNEUTA

NDC: 72893-016
Generic name: efbemalenograstim alfa-vuxw
Labeler / Manufacturer: Acrotech Biopharma Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20231123

FDA application: BLA761134

## Active ingredients

- EFBEMALENOGRASTIM ALFA: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72893-016"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72893-016
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=290ed754-758c-9cae-e063-6294a90ae68b